MichaelR.McClungMD

PubMed

• Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk.
  Michael R McClung, Donald Betah, Cynthia Deignan, Yifei Shi, Jen Timoshanko, Felicia Cosman> ;Endocrine Practice. 2023 Sep 1
• 3 citations
  Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases.
  E Michael Lewiecki, John P Bilezikian, Neil Binkley, Mary L Bouxsein, Susan V Bukata, David W Dempster, Matthew T Drake, Michael R McClung, Paul D Miller, Elisabeth Ro...> ;Journal of Clinical Densitometry. 2022 Oct 15
• 1 citations
  An updated hip fracture incidence rate for Brazil: the Brazilian Validation Osteoporosis Study (BRAVOS).
  Ben-Hur Albergaria, Cristiano A F Zerbini, Vera Lucia Szejnfeld, Sergio Ragi Eis, Dalisbor Marcelo Weber Silva, Maria de Fatima Lobato da Cunha, Michael R McClung, Joh...> ;Archives of Osteoporosis. 2022 Jul 2
• 4 citations
  The role of osteoanabolic agents in the management of patients with osteoporosis.
  Michael R McClung, Micol S Rothman, E Michael Lewiecki, David A Hanley, Steven T Harris, Paul D Miller, David L Kendler> ;Postgraduate Medicine. 2022 Aug 1
• LETTERS TO THE EDITOR.
  Michael R McClung> ;Menopause. 2022 Mar 25
• Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms.
  Michael R McClung, Risa Kagan, Shelli Graham, Brian Bernick, Sebastian Mirkin, Ginger Constantine> ;Menopause. 2022 Feb 14
• 6 citations
  Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases.
  E Michael Lewiecki, Paul A Anderson, John P Bilezikian, Neil Binkley, Angela M Cheung, Erik A Imel, Diane Krueger, Michael R McClung, Paul D Miller, Micol S Rothman> ;Journal of Clinical Densitometry. 2021 Oct 9
• 4 citations
  Osteoanabolic therapy for osteoporosis in women.
  M R McClung, A L Clark> ;Climacteric. 2021 Aug 3
• 16 citations
  Skeletal responses to romosozumab after 12 months of denosumab
  Michael R. McClung, Michael A. Bolognese, Jacques P. Brown, Jean-Yves Reginster, Bente L. Langdahl, Yifei Shi, Jen Timoshanko, Cesar Libanati, Arkadi Chines, Mary Oates> ;JBMR Plus. 2021 Jun 3
• 7 citations
  Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan
  H. Hagino, Kiyoshi Tanaka, S. Silverman, Michael R. McClung, Shravanthi R. Gandra, M. Charokopou, K. Adachi, B. Johnson, B. Stollenwerk> ;Osteoporosis International. 2021 Mar 27
• 10 citations
  Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial
  Socrates E. Papapoulos, Henry G. Bone, Felicia Cosman, David W. Dempster, Michael R. McClung, Toshitaka Nakamura, José Fernando Molina Restrepo, Mary L. Bouxsein, D Co...> ;Journal of Bone and Mineral Research. 2021 Apr 27
• 19 citations
  Role of bone-forming agents in the management of osteoporosis
  Michael R. McClung> ;Aging Clinical and Experimental Research. 2021 Feb 16
• 10 citations
  Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis
  Chih Hsing Wu, Wei Chieh Hung, Ing Lin Chang, Tsung Ting Tsai, Yin Fan Chang, Eugene V. McCloskey, Nelson B. Watts, Michael R. McClung, Chun Feng Huang, Chung-Hwan Che...> ;Bone Reports. 2020 Oct 27
• 4 citations
  Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.
  Susan L. Greenspan, Lorraine A. Fitzpatrick, Bruce H. Mitlak, Yamei Wang, Nicholas C. Harvey, Chad L. Deal, Felicia Cosman, Michael R. McClung> ;Menopause. 2020 Oct 1
• 24 citations
  A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
  Michael R. McClung, Michael A. Bolognese, Jacques P. Brown, Jean-Yves Reginster, Bente L. Langdahl, Judy Maddox, Yifei Shi, Maria Rojeski, Paul D Meisner, Andreas Grauer> ;Osteoporosis International. 2020 Jul 4
• 11 citations
  History of risedronate.
  Michael R. McClung, Frank H. Ebetino> ;Bone. 2020 May 6
• 78 citations
  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTE...
  Pauline M Camacho, Steven M Petak, Neil Binkley, Dima L Diab, Leslie S Eldeiry, Azeez Farooki, Steven T Harris, Daniel L Hurley, Jennifer Kelly, E Michael Lewiecki, Ra...> ;Endocrine Practice. 2020 May 1
• 366 citations
  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTE...
  Pauline M Camacho, Steven M Petak, Neil Binkley, Dima L Diab, Leslie S Eldeiry, Azeez Farooki, Steven T Harris, Daniel L Hurley, Jennifer Kelly, E Michael Lewiecki, Ra...> ;Endocrine Practice. 2020 May 1
• 64 citations
  Bone Mineral Density After Transitioning From Denosumab to Alendronate
  David L. Kendler, Arkadi Chines, Patricia Clark, Peter R. Ebeling, Michael R. McClung, Yumie Rhee, Shuang Huang, Robert Kees Stad> ;The Journal of Clinical Endocrinology and Metabolism. 2020 Mar 1
• 17 citations
  A pooled analysis of fall incidence from placebo-controlled trials of Denosumab
  Pojchong Chotiyarnwong, Eugene V. McCloskey, Richard Eastell, Michael R. McClung, Evelien Gielen, John Gostage, Michele McDermott, Arkadi Chines, Shuang Huang, Steven ...> ;Journal of Bone and Mineral Research. 2020 Jan 30
• 23 citations
  Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk
  Mary L. Bouxsein, Philippe K. Zysset, Claus-Christian Glüer, Michael R. McClung, Emmanuel Biver, D. D. Pierroz, Serge Ferrari> ;Osteoporosis International. 2020 Jan 3
• 9 citations
  Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases.
  E. Michael Lewiecki, John P. Bilezikian, Risa Kagan, Deborah Krakow, Michael R. McClung, Paul D. Miller, Eric T. Rush, Christopher R. Shuhart, Nelson B. Watts, Elaine ...> ;Journal of Clinical Densitometry. 2020 Jan 1
• 10 citations
  Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis.
  E. Michael Lewiecki, David L. Kendler, K. Shawn Davison, David A. Hanley, Steven T. Harris, Michael R. McClung, Paul D. Miller> ;The American Journal of Medicine. 2019 May 29
• 93 citations
  Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
  Loft Investigators> ;The Lancet. Diabetes & Endocrinology. 2019 Dec 1
• 39 citations
  Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years
  Nelson B. Watts, John T. Grbic, Neil Binkley, S. Papapoulos, Peter W. Butler, Xiang Yin, Antoniette Tierney, Rachel B. Wagman, Michael R. McClung> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Jun 1
• Join now to see all